Surveillance and Active Monitoring Strategies for Cancer: Sometimes Less Is More

Dear Colleagues,

We are working on a Special Issue for Current Oncology titled “Surveillance and Active Monitoring Strategies for Cancer: Sometimes Less Is More”. We are pleased to invite you to contribute a paper to this Special Issue, considering your expertise in Urologic Oncology. This Special Issue aims to describe the current state of the art and contemporary outcomes of different surveillance and active monitoring strategies for patients with genitourinary cancer. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: prostate cancer, non-muscle-invasive bladder cancer, small renal masses, renal cell carcinoma, small testicular masses, CS I testicular cancer, adrenal neoplasms, etc. We look forward to receiving your contributions.

The aim of this Special Issue is to describe the current state of the art and contemporary outcomes of different surveillance and active monitoring strategies for patients with cancer.

The scope of this Special Issue includes a comprehensive examination of surveillance and active monitoring strategies across various types of cancer, including but not limited to prostate cancer, renal cancer, non-muscle-invasive bladder cancer, small testicular masses, and adrenal incidentalomas.

Furthermore, we aim to explore the different surveillance strategies used in cancer management, such as imaging techniques (e.g., computed tomography, magnetic resonance imaging, ultrasound), biomarker assessments (e.g., blood tests, genetic markers), and clinical evaluation methods (e.g., physical examination, symptom monitoring).

The scope of this issue also involves evaluating the outcomes associated with different surveillance and active monitoring strategies for cancer patients. This includes assessing the effectiveness of these strategies in detecting cancer progression and improving survival rates, enhancing quality of life, and minimizing unnecessary interventions.

Additionally, we aim to understand the perspectives and experiences of cancer patients regarding surveillance and active monitoring strategies. This could involve examining patient satisfaction, preferences, adherence to monitoring protocols, and the impact of these strategies on their overall well-being.

Dr. Rashid K Sayyid
Dr. Julian Chavarriaga
Dr. Rui Bernandino
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• surveillance
• watchful waiting
• active monitoring
• cancer
• survival